According to BlockBeats, AminoChain has successfully completed a $5 million seed round of financing, with a16z leading the investment. This marks the first time a16z has invested in a 'DeSci' (decentralized science) project.
AminoChain is developing a Layer 2 blockchain protocol aimed at connecting corporate medical institutions and creating user-owned decentralized healthcare applications. The initial application on this protocol is a biospecimen market, which enables researchers to query and license samples through a network of biospecimen banks. Patients can track the usage of their samples, gain insights from new research generated from these samples, and earn money by selling them.
